We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL3 is potential prognostic, high expression is unfavorable in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
1635.9
Number of samples
349
Samples
Sample
Description
TPM
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
5450.2
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
4271.5
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
4224.0
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
3814.2
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
3766.1
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
3588.6
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
3553.2
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
3516.8
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
3476.5
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
3430.6
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
3387.3
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
3248.4
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
3226.2
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
3191.3
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
3183.5
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
3152.2
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
3127.9
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
3083.9
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
3075.3
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
3049.5
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
3022.2
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
2944.2
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
2932.2
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
2908.4
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
2899.9
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
2880.3
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
2876.0
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
2860.8
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
2829.3
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
2800.6
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
2766.6
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
2761.7
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
2758.8
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
2688.7
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
2678.1
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
2603.5
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
2594.6
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
2570.4
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
2555.5
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
2542.4
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
2534.3
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
2516.2
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
2501.7
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
2485.5
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
2484.0
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
2469.8
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
2416.6
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
2389.2
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
2388.9
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
2381.4
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
2370.5
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
2340.6
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
2333.9
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
2315.5
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
2314.5
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
2292.3
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
2280.8
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
2277.5
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
2268.4
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
2265.1
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
2263.1
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
2253.9
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
2234.6
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
2232.5
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
2204.1
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
2191.7
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
2185.2
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
2185.1
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
2171.7
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
2164.3
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
2145.7
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
2144.2
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
2116.9
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
2110.9
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
2097.1
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
2096.9
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
2074.8
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
2072.6
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
2060.5
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
2049.2
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
2046.8
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
2043.6
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
2037.9
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
2037.1
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
2034.7
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
2029.4
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
2027.2
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
2021.6
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
2007.3
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
1992.7
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
1991.1
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
1981.9
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
1963.7
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
1949.4
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
1938.7
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
1934.9
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
1927.6
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
1919.5
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
1904.8
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
1900.6
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
1896.4
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
1879.7
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
1869.3
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
1867.1
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
1866.3
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
1862.3
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
1856.7
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
1850.0
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
1848.3
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
1847.1
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
1840.3
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
1822.5
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
1815.9
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
1814.8
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
1807.2
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
1806.3
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
1803.2
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
1802.1
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
1798.1
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
1797.5
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
1794.9
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
1793.6
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
1790.9
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
1784.9
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
1760.1
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
1756.4
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
1756.2
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
1732.4
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
1731.6
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
1721.8
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
1705.9
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
1699.6
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
1690.1
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
1685.2
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
1681.6
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
1671.4
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
1647.5
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
1638.3
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
1637.4
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
1637.2
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
1631.4
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
1626.4
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
1626.1
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
1614.8
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
1611.6
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
1611.5
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
1589.7
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
1582.1
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
1566.6
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
1566.6
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
1564.3
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
1564.0
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
1552.9
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
1548.3
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
1525.7
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
1522.8
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
1521.3
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
1520.1
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
1513.4
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
1511.5
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
1499.4
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
1495.3
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
1488.9
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
1482.3
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
1478.0
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
1475.1
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
1471.5
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
1467.9
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
1463.4
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
1461.6
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
1459.5
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
1456.8
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
1454.1
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
1448.4
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
1445.8
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
1443.9
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
1434.4
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
1426.9
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
1424.3
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
1424.2
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
1419.3
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
1417.8
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
1410.4
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
1408.5
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
1406.7
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
1402.7
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
1385.3
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
1379.4
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
1378.6
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
1375.4
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
1367.2
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
1366.4
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
1348.7
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
1343.3
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
1342.4
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
1340.0
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
1329.7
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
1329.3
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
1326.9
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
1325.3
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
1317.5
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
1316.6
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
1315.4
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
1313.8
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
1312.7
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
1305.0
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
1304.8
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
1304.1
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
1300.9
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
1298.6
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
1295.5
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
1294.8
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
1294.2
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
1288.0
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
1286.6
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
1277.9
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
1276.1
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
1274.8
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
1269.6
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
1260.5
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
1254.6
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
1252.6
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
1250.3
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
1248.0
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
1223.2
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
1220.0
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
1219.0
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
1217.2
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
1206.5
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
1198.7
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
1193.9
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
1193.5
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
1188.2
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
1185.5
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
1182.7
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
1181.9
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
1181.8
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
1179.4
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
1176.9
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
1175.3
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
1174.5
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
1171.3
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
1170.2
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
1168.1
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
1168.1
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
1162.9
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
1155.0
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
1153.0
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
1151.3
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
1149.5
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
1149.3
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
1149.0
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
1141.0
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
1140.4
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
1136.9
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
1135.8
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
1128.7
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
1122.7
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
1121.7
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
1117.7
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
1112.6
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
1112.6
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
1112.4
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
1107.6
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
1104.0
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
1099.3
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
1097.4
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
1094.5
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
1092.2
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
1089.4
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
1083.5
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
1075.0
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
1074.6
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
1073.7
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
1072.4
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
1071.0
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
1070.9
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
1068.7
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
1062.3
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
1062.1
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
1062.0
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
1060.6
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
1060.3
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
1057.9
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
1055.4
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
1054.1
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
1053.4
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
1041.4
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
1039.4
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
1031.5
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
1029.8
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
1024.8
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
1015.3
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
1006.0
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
1006.0
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
1004.1
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
1001.8
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
1000.5
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
997.7
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
994.9
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
985.8
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
979.3
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
977.6
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
976.9
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
975.4
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
953.5
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
946.6
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
938.6
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
935.6
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
935.4
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
929.1
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
923.7
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
906.9
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
902.0
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
890.1
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
886.1
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
878.4
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
876.7
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
864.2
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
861.8
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
846.8
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
844.5
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
834.7
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
822.9
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
821.4
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
816.7
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
812.4
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
811.7
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
809.1
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
802.8
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
800.4
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
796.2
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
789.6
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
782.1
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
772.0
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
768.3
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
768.3
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
760.5
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
756.7
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
755.9
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
752.7
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
744.0
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
713.6
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
672.5
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
639.5
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
599.6
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
573.1
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
364.7
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL3 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
2391.9
Number of samples
81
Samples
Sample
Description
TPM
DO46326
0 years, female, NA, stage:III, dead, 701 days
4895.6
DO46390
0 years, female, NA, stage:III, dead, 374 days
4724.0
DO46356
0 years, female, NA, stage:III, dead, 911 days
4638.3
DO46611
0 years, female, NA, stage:III, dead, 734 days
4598.5
DO46384
0 years, female, NA, stage:III, dead, 614 days
4453.2
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
4434.5
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
4096.2
DO46402
0 years, female, NA, stage:III, dead, 511 days
3902.3
DO46338
0 years, female, NA, stage:III, dead, 596 days
3823.3
DO46330
0 years, female, NA, stage:III, dead, 684 days
3582.2
DO46518
0 years, female, NA, stage:III, alive, 2960 days
3483.1
DO46591
0 years, female, NA, stage:III, dead, 195 days
3429.7
DO46370
0 years, female, NA, stage:III, dead, 1727 days
3354.0
DO46325
0 years, female, NA, stage:III, dead, 477 days
3332.3
DO46493
0 years, female, NA, stage:IV, alive, 839 days
3299.4
DO46551
0 years, female, NA, stage:III, dead, 1055 days
3179.1
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
3150.3
DO46342
0 years, female, NA, stage:III, dead, 1398 days
3127.1
DO46350
0 years, female, NA, stage:III, dead, 886 days
3055.6
DO46412
0 years, female, NA, stage:III, dead, 597 days
2897.9
DO46400
0 years, female, NA, stage:III, dead, 719 days
2869.6
DO46352
0 years, female, NA, stage:III, dead, 677 days
2787.5
DO46378
0 years, female, NA, stage:III, alive, 843 days
2777.5
DO46368
0 years, female, NA, stage:III, dead, 2879 days
2764.6
DO46443
0 years, female, NA, stage:III, dead, 2464 days
2663.8
DO46538
0 years, female, NA, stage:III, dead, 1527 days
2614.9
DO46328
0 years, female, NA, stage:III, dead, 972 days
2532.2
DO46597
0 years, female, NA, stage:III, dead, 393 days
2522.3
DO46374
0 years, female, NA, stage:III, dead, 1409 days
2507.1
DO46364
0 years, female, NA, stage:III, dead, 806 days
2499.5
DO46354
0 years, female, NA, stage:III, dead, 843 days
2495.3
DO46568
0 years, female, NA, stage:III, dead, 320 days
2462.4
DO46508
0 years, female, NA, stage:III, dead, 2101 days
2411.9
DO46334
0 years, female, NA, stage:III, dead, 496 days
2408.5
DO46581
0 years, female, NA, stage:III, dead, 408 days
2390.1
DO46398
0 years, female, NA, stage:III, alive, 437 days
2316.3
DO46333
0 years, female, NA, stage:III, dead, 359 days
2304.0
DO46453
0 years, female, NA, stage:III, dead, 3294 days
2297.3
DO46392
0 years, female, NA, stage:III, dead, 628 days
2258.3
DO46576
0 years, female, NA, stage:III, alive, 133 days
2220.9
DO46346
0 years, female, NA, stage:III, dead, 1187 days
2182.2
DO46358
0 years, female, NA, stage:III, dead, 423 days
2100.4
DO46386
0 years, female, NA, stage:III, dead, 1162 days
2069.7
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
2069.4
DO46376
0 years, female, NA, stage:III, dead, 1430 days
2048.8
DO46366
0 years, female, NA, stage:III, dead, 2054 days
2015.1
DO46380
0 years, female, NA, stage:III, dead, 1423 days
2014.9
DO46560
0 years, female, NA, stage:IV, dead, 286 days
2005.9
DO46436
0 years, female, NA, stage:III, alive, 3193 days
1988.8
DO46561
0 years, female, NA, stage:III, dead, 195 days
1966.8
DO46546
0 years, female, NA, stage:III, dead, 1889 days
1909.5
DO46362
0 years, female, NA, stage:III, dead, 1639 days
1895.1
DO46372
0 years, female, NA, stage:III, dead, 1326 days
1856.3
DO46388
0 years, female, NA, stage:III, dead, 413 days
1855.8
DO46396
0 years, female, NA, stage:III, dead, 583 days
1822.0
DO46571
0 years, female, NA, stage:III, dead, 243 days
1784.5
DO46448
0 years, female, NA, stage:III, dead, 654 days
1780.9
DO46344
0 years, female, NA, stage:III, dead, 642 days
1777.2
DO46533
0 years, female, NA, stage:III, alive, 3667 days
1758.7
DO46331
0 years, female, NA, stage:III, dead, 612 days
1754.5
DO46602
0 years, female, NA, stage:III, dead, 205 days
1732.4
DO46468
0 years, female, NA, stage:III, alive, 2776 days
1718.8
DO46432
0 years, female, NA, stage:III, alive, 2218 days
1654.9
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
1615.4
DO46566
0 years, female, NA, stage:III, dead, 673 days
1593.5
DO46463
0 years, female, NA, stage:III, dead, 2451 days
1574.2
DO46404
0 years, female, NA, stage:III, dead, 690 days
1564.1
DO46348
0 years, female, NA, stage:IV, dead, 287 days
1541.1
DO46336
0 years, female, NA, stage:IV, dead, 664 days
1496.6
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
1481.8
DO46408
0 years, female, NA, stage:III, dead, 489 days
1461.7
DO46382
0 years, female, NA, stage:IV, dead, 311 days
1396.7
DO46327
0 years, female, NA, stage:III, dead, 184 days
1378.5
DO46528
0 years, female, NA, stage:III, alive, 6139 days
1326.8
DO46340
0 years, female, NA, stage:III, dead, 616 days
1292.1
DO46586
0 years, female, NA, stage:III, dead, 1019 days
1284.4
DO46606
0 years, female, NA, stage:III, alive, 804 days
1282.8
DO46332
0 years, female, NA, stage:III, dead, 689 days
1190.1
DO46588
0 years, female, NA, stage:III, dead, 438 days
1139.7
DO46329
0 years, female, NA, stage:III, dead, 1699 days
1125.6
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
683.4
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
1.0
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
0.6
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
0.6
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
0.6
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
0.6
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
0.6
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
0.5
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
0.5
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
0.5
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
0.5
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
0.5
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.5
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.5
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
0.4
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
0.4
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.4
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
0.4
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
0.4
161317f3-1a39-438e-af45-cd2502_D2
Tumor
0.3
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
0.3
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
0.3
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
0.3
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
0.3
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
0.3
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
0.3
1772e913-f62e-446a-8cf3-720348_D2
Tumor
0.3
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
0.3
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.3
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
0.3
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.3
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
0.3
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.3
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.3
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
0.2
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
0.2
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
0.2
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
0.2
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
0.2
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
0.2
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
0.2
10c2d629-0287-4511-ac25-f29031_D2
Tumor
0.2
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
0.2
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
0.2
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.2
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
0.2
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
0.1
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
0.1
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
0.1
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
0.1
2f901c90-617e-46da-9fac-d68369_D2
Tumor
0.1
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.1
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.1
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.1
15524912-685a-47ce-a824-567848_D2
Tumor
0.1
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
0.1
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
0.1
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
0.1
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
0.1
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
0.1
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
0.0
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.0
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
0.0
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
0.0
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
0.0
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
0.0
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
0.0
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.0
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
0.0
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.0
e9d416e7-f661-400a-896e-388545_D2
Tumor
-0.1
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
-0.1
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
-0.1
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
-0.1
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
-0.1
1a10c200-3895-4648-b951-94f99f_D2
Tumor
-0.1
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
-0.1
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
-0.2
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
-0.2
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
-0.2
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
-0.2
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
-0.2
340a3769-3031-41ae-bb08-a2f696_D2
Normal
-0.2
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
-0.2
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
-0.3
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.3
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.3
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
-0.3
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.3
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
-0.4
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-0.4
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
-0.4
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-0.4
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-0.4
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.4
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.4
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-0.4
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-0.5
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
-0.5
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-0.5
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-0.5
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-0.5
a3a26070-fb84-406a-8280-d555e6_D2
Normal
-0.5
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.6
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
-0.6
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
-0.6
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.7
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.7
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-0.8
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.